Clinical trial · Observational
Clinical-immunological Features of Anti-NMDAR Encephalitis
NCT05738668CI-TRIAL-00064140Bio-NMDArunknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Using a retrospective cohort of 501 patients with anti-NMDAR encephalitis to assess clinical and immunological prognostic biomarkers
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Anti NMDA Receptor Encephalitis | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Description of clinical characteristic | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Anti-NMDAR encephalitis
- description
- Patients with well-characterized anti-NMDAR encephalitis.
- interventionNames
- Other: Description of clinical characteristic
Primary outcomes (1)
- measure
- Modified Rankin scale (mRS)
- timeFrame
- Baseline
- description
- Scale for measuring the degree of dependence in the daily activities of people who have suffered of neurological disability. 0 - No symptoms. 1. \- No significant disability. Able to carry out all usual activities, despite some symptoms. 2. \- Slight disability. Able to look after own affairs without assistance, but unable to carry out all previous activities. 3. \- Moderate disability. Requires some help, but able to walk unassisted. 4. \- Moderately severe disability. Unable to attend to own bodily needs without assistance, and unable to walk unassisted. 5. \- Severe disability. Requires constant nursing care and attention, bedridden, incontinent. 6. \- Dead.
Eligibility
Eligibility (as posted)
Show eligibility criteria text
Inclusion Criteria: * Patient with neurological disorder * Patient with NMDAR antibodies in sera or CSF Exclusion Criteria: * \- No available clinical data * Patient without NMDAR antibodies or neurological disorder
References
Publications (0)
Data not yet available
No reference posted for this study.